Apollo Endosurgery today priced a stock offering worth nearly $21 million for its line of bariatric and gastrointestinal devices. Austin, Texas-based Apollo said it plans to float roughly 3.75 million shares at $5.50 apiece, for gross proceeds of $20.6 million. The offering also includes a 45-day option for underwriter Craig-Hallum Capital of another 562,055 shares, […]
EnteroMedics (NSDQ:ETRM) said today that it acquired BarioSurg and the gastric vest it developed to treat obesity, sending share prices surging in pre-market trading. The BarioSurg device is designed to be implanted via laparoscopy to wrap the stomach and emulate the effects of conventional bariatric surgery by temporarily reducing the stomach’s volume. St. Paul, Minn.-based […]
Gelesis just last week drummed up a $22 million funding round, but that’s not stopping the Boston-based company from registering for an initial public offering worth $60 million.
California’s Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.
Apollo Endosurgery said it secured a $50 million term loan from Athyrium Capital Management it plans to use to refinance its debt.